Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein A1 pseudogene 24 (HNRNPA1P24)
- Target
- HNRNPA1P24
- Molecular classification
- Pseudogene
01
Overview
Heterogeneous nuclear ribonucleoprotein A1 pseudogene 24 (HNRNPA1P24) is a processed pseudogene derived from the heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1) gene. It is located in intergenic regions and lacks protein-coding ability[1][3][5]. While some pseudogenes may be transcribed or exert regulatory effects in certain biological contexts, there is currently no evidence of functional protein expression or disease association for HNRNPA1P24. In contrast, the parental HNRNPA1 gene encodes a protein important in RNA binding, splicing, nuclear-cytoplasmic transport, and cellular stress responses, and has been implicated as a biomarker and potential therapeutic target in cancer and neurodegenerative conditions[4][2][6][3].
- Other names
- HNRNPA1P24
02
Mechanism of action
None known, as HNRNPA1P24 is not a therapeutic target.
03
Biological functions
None definitively established for HNRNPA1P24Pseudogenes may have regulatory roles (e.g., competing endogenous RNAs, influencing parental gene expression), but no such activities have been specifically attributed to HNRNPA1P24
04
Disease associations
No specific disease roles established for HNRNPA1P24
05
Safety considerations
None known
06
Interacting drugs
None known
07
Biomarkers
None known
Beyond the preview
Go deeper on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 24 (HNRNPA1P24).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 24 (HNRNPA1P24).